SCHEMBL29133742

SCHEMBL29133742

CCC1(Nc2ncnc3ccc(-c4cnc5[nH]nnc5c4)cc23)C=CC=CC1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IRAK4 Q9NWZ3 9/20 0.35
▸ MAP4K4 O95819 1/20 0.35
▸ CLK1 P49759 3/20 0.35
▸ CD38 P28907 1/20 0.34
▸ CLK4 Q9HAZ1 5/20 0.34
▸ CYP1A2 P05177 3/20 0.34
▸ CYP3A4 P08684 3/20 0.34
▸ CYP2D6 P10635 3/20 0.34
▸ CLK2 P49760 2/20 0.34
▸ CLK3 P49761 2/20 0.34
▸ DYRK1A Q13627 2/20 0.34
▸ DYRK1B Q9Y463 2/20 0.34
▸ USP2 O75604 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ RAF1 P04049 1/20 0.34
▸ BRAF P15056 1/20 0.34
▸ CYP2C19 P33261 2/20 0.33
▸ PIK3CA P42336 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29133728 0.84 IRAK4 (0.48) IRAK4MAP4K4CLK1CD38CLK4
SCHEMBL29133716 0.83 IRAK4 (0.39) IRAK4MAP4K4CLK1CLK4CYP1A2
SCHEMBL29133705 0.82 EGFR (0.41) DYRK1ADYRK1BPIK3CA
SCHEMBL29133774 0.81 IRAK4 (0.47) IRAK4MAP4K4CD38CLK4CYP1A2
SCHEMBL29133732 0.81 PIK3CA (0.52) IRAK4CYP1A2CYP3A4CYP2D6USP2
SCHEMBL29133743 0.78 PIK3CA (0.53) MAP4K4CLK1CLK4CYP1A2CYP3A4
SCHEMBL29133745 0.78 HTT (0.50) IRAK4CYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL29133739 0.78 HTT (0.50) IRAK4CYP1A2CYP3A4CYP2D6ALDH1A1
SCHEMBL29133735 0.77 HTT (0.36) IRAK4MAP4K4CLK1CD38CLK4
SCHEMBL29133752 0.77 HTT (0.36) IRAK4MAP4K4CLK1CD38CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295716-A Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors 麦克尼斯迪克治疗有限公司 2023-12-26 — — CN disclosed
Send feedback